SCHEMBL6772109

SCHEMBL6772109

CC(C)c1ccc(-n2nc(-c3cnc4ccccc4n3)c3c2C(C#N)C(C)(C)CC3=O)cc1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CCNA2 P20248 10/20 0.37
▸ CDK2 P24941 10/20 0.37
▸ DHODH Q02127 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ CDK5 Q00535 2/20 0.31
▸ CDK5R1 Q15078 2/20 0.31
▸ CCNO P22674 1/20 0.31
▸ CCNE1 P24864 1/20 0.31
▸ CCNA1 P78396 1/20 0.31
▸ SRC P12931 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6767386 0.87 DHODH (0.32) DHODHMEN1LMNACYP1A2CYP3A4
SCHEMBL6772430 0.84 CCNA2 (0.44) CCNA2CDK2DHODHMEN1LMNA
SCHEMBL6167422 0.82 NPSR1 (0.36) MEN1KMT2A
SCHEMBL6775773 0.80 CCNA2 (0.39) CCNA2CDK2DHODHMEN1LMNA
SCHEMBL6770739 0.80 CCNA2 (0.45) CCNA2CDK2MEN1LMNACYP1A2
SCHEMBL6776854 0.79 PTGS1 (0.42) CCNA2CDK2MEN1LMNACYP1A2
SCHEMBL6771336 0.79 CCNA2 (0.37) CCNA2CDK2DHODHMEN1LMNA
SCHEMBL6767158 0.78 CCNA2 (0.37) CCNA2CDK2MEN1LMNACYP1A2
SCHEMBL6772549 0.78 CCNA2 (0.35) CCNA2CDK2MEN1LMNACYP1A2
SCHEMBL6772794 0.77 CCNA2 (0.40) CCNA2CDK2DHODHMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 — — US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 — — EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 — — WO disclosed
Send feedback